PMID: 22552452May 4, 2012Paper

A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
Ghamartaj KhanbabaeeNima Rezaeig

Abstract

This study was performed to investigate frequency and antimicrobial susceptibility of pulmonary pathogens in cystic fibrosis (CF) patients. 129 pediatric patients with CF were enrolled in this cross-sectional study. Microbiological cultures were performed based on sputum or pharyngeal swabs. Antibiotic susceptibilities of the isolated bacteria were determined by the disk diffusion method. The main infecting pathogens were Pseudomonas aeruginosa (38.8%), Klebsiella pneumoniae (11.6%) and Staphyloccus areus (9.3%), respectively. The most active antibiotics included rifampin (91.7% susceptibility), vancomycin (85%) and imipenem (83.5%). Emerging resistance against aminoglycosides was observed. Regarding in vitro susceptibility results, cyclic treatment of long-term oral azithromycin and inhaled tobramycin could prophylactically be applied, and during exacerbations, imipenem or ceftazidime in combination with an aminoglycoside such as amikacin could be considered the drugs of choice.

References

Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L BurnsC R Clausen
Oct 24, 2002·Current Opinion in Pulmonary Medicine·Thao NguyenMark A Gill
May 7, 2004·The New England Journal of Medicine·Yujiro Kida
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Omar M PirzadaMark L Everard
Oct 29, 2004·Current Opinion in Pulmonary Medicine·Lisa Saiman
Nov 2, 2004·The European Respiratory Journal·K W Southern, P M Barker
Aug 19, 2007·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Giuseppe ValenzaMarianne Abele-Horn
Mar 26, 2008·Pediatric Pulmonology·Hara LevyA A Colin
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J WolterNancy D Hanson
Jul 22, 2008·The Journal of Pediatrics·Philip M FarrellUNKNOWN Cystic Fibrosis Foundation
Oct 14, 2008·Expert Review of Anti-infective Therapy·Michael R Jacobs
Apr 28, 2009·Respiratory Care·Felix A Ratjen
Apr 28, 2009·Respiratory Care·Jane C Davies, Diana Bilton
Sep 15, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Felix RatjenGerhild Angyalosi
Mar 17, 2010·Pediatric Pulmonology·Julia EmersonJane L Burns
Jul 6, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V CafisoS Stefani
Jul 31, 2010·Pediatric Pulmonology·Hanne Vebert OlesenUNKNOWN Scandinavian Cystic Fibrosis Study Consortium
Aug 10, 2010·Paediatric Respiratory Reviews·Bridget StuartPeter J Mogayzel
Dec 15, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Yasunori MaedaJohn E Moore
Jan 12, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Robson S LeãoElizabeth A Marques

❮ Previous
Next ❯

Citations

Mar 5, 2015·Pathogens·Louise Cullen, Siobhán McClean
Mar 22, 2014·Critical Reviews in Microbiology·Susana P LopesMaria O Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.